Article
08 Apr 2025
Global Biosimilar Updates – Spring 2025
AUTHORS CONTENT
Article
15 Jan 2025
Year In Review: Top Regulatory Developments Of 2024
Article
24 Oct 2024
Teva's Denosumab Biosimilar Candidate Is Accepted For Review By FDA And EMA
Article
17 Sep 2024
Alexion And Samsung Settle Eculizumab BPCIA Case
Article
08 Aug 2024
EU Committee Recommends Approval Of 6 New Biosimilars In July 2024 Meeting
Article
26 Apr 2024
FDA Approval Of Alvotech/Teva Ustekinumab Biosimilar
Article
01 Apr 2024
Biden Administration Proposes Biosimilar Substitution Without Interchangeability
Article
28 Feb 2024
FDA Issues A Final Rule On Biologics License Applications, Investigational New Drug Applications And Master Files